Direct-to-Consumer (DTC) Genetic Testing Market - By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, Skincare Testing), By Technology, By Distribution Channel & Forecast, 2023-2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationDirect-to-Consumer (DTC) Genetic Testing Market - By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, Skincare Testing), By Technology, By Distribution Channel & Forecast, 2023-2032
Direct-to-Consumer Genetic Testing Market Size
Direct-to-Consumer Genetic Testing Market size surpassed USD 3 billion in 2022 and is predicted to expand at over 11.5% CAGR from 2023-2032. Rising prevalence of genetic disorders will accelerate industry growth.
A dramatic rise in the incidences of genetic disorders such as cystic fibrosis, Sickle cell disease, Alzheimer’s disease (AD), and some cancers is expected to proliferate the demand for DTC genetic tests. For instance, as per the 2022 report by the National Institute of Health (NIH), nearly 6.5 million people above 65 years of age in the U.S. have AD-related dementia and the patient pool is estimated to exceed 13.5 million by 2060 in case of a dearth in medical breakthroughs.
The increasing focus on customized healthcare solutions has fostered the substantial demand for personalized DTC genetic tests, particularly across developing countries with burgeoning medical needs. Additionally, leading industry players are implementing strategic deals to provide modern testing services on online platforms with improved accessibility. For instance, in October 2021, 23andMe announced plans to acquire Lemonaid Health, a virtual healthcare, and pharmacy platform to combine personalized genetics services and primary care.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Direct-to-Consumer Genetic Testing Market Size in 2022 | USD 3 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 11.5% |
| 2032 Value Projection | USD 10.5 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 190 |
| Tables, Charts & Figures | 316 |
| Segments covered | Test Type, Technology, Distribution Channel and Region. |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
High pricing model of DTC kits may impede product demand
High costs associated with DTC genetic testing services could hamper the direct-to-consumer genetic testing market outlook. A large number of manufacturers are focusing on product innovations and integration of next-generation technologies to introduce high-end DTC tests, leading to higher product pricing. For instance, based on the complexity of the test and severity of the disease, the cost of DTC genetic tests varies from USD 100 to USD 3,000. Hence, the demand for genetic services across underdeveloped and developing regions could potentially reduce with affordability issues.
Direct-to-Consumer (DTC) Genetic Testing Market Analysis
Predictive testing held more than 19% share of the DTC genetic testing market in 2022. The ongoing advancements and upgrades of platforms to enhance the efficiency of genome analysis procedures are expected to boost the adoption of predictive testing solutions. Increasing focus on reducing the healthcare burden of rare genetic disorders is fueling the need for presymptomatic testing to effectively assess and prevent future complications, thus curbing the rising mortality rates. Furthermore, the rapid integration of technologies such as machine learning, and artificial intelligence will boost the product development.
Personalized Health TestsA Growing Market for Your DNA The world of genetic testing is booming, and more people than ever are turning to over-the-counter (OTC) tests to learn about their health. It's like having your own DNA detective kit! By 2032, experts say the OTC segment will bring in over 2 billion dollars. This is because people are loving the convenience and affordability of these tests. Unlike traditional tests that require a doctor's visit, OTC kits let you test your DNA from home. Plus, there's a ton of different OTC tests to choose from. You can learn about your risk of inherited diseases, like cancer or heart problems. Or you can find out what health conditions might run in your family. These tests have become especially popular since the COVID-19 pandemic. Staying home made doing tests like these a lot easier and safer.
The market for at-home genetic testing kits using the latest technology called SNP chips is expected to grow rapidly in the next decade, with an anticipated growth rate of over 12% per year from 2023 to 2032. SNP chips are becoming increasingly popular because they offer more accurate and detailed results for genetic tests. They can detect both changes in the number of genes (dosage changes) and variations in the DNA sequence (DNA polymorphism). This makes them useful for a wide range of applications, including cancer research and the development of personalized treatments. As people become more aware of the importance of accurate genetic information, the demand for SNP chips is expected to continue to grow. This will help drive the growth of the overall market for at-home genetic testing kits.
Europe DTC genetic testing market size is poised to surpass USD 2.7 billion by 2032 owing to the surging number of patients suffering from rare chronic illnesses and the subsequently reduced quality of life. As a result, several EU bodies are implementing ambitious strategies to curb the mortality rate and improve care for patients with rare genetic conditions, offering lucrative business prospects for DTC genetic testing providers in the region. U.S. direct-to-consumer genetic testing industry is poised to grow at over 11% CAGR from 2023 to 2032, driven by the growing occurrence of genetic disorders across the globe.
Direct-to-Consumer (DTC) Genetic Testing Market Share
Some of the leading companies in the global direct-to-consumer genetic testing market include
- Full Genome Corporation Inc.
- 23andMe, Inc.
- Ancestry
- Counsyl
- Gene by Gene
- Easy DNA
- Helix OpCo LLC
- Living DNA Ltd.
- Karmagenes SA
- Mapmygenome
- Pathway genomics
- Identigene
- Genesis Healthcare Co.
- The SkinDNA Company Pty Ltd
- MyHeritage
- Ambry Genetics
- DNA Genotek Inc
- Dante Lab
- Blueprint Genetics Oy
- DNA Diagnostic Center
- HomeDNA
These participants are focusing on the development of novel products to strengthen their business identity.
Impact of the COVID-19 pandemic
The COVID-19 pandemic positively influenced the DTC genetic testing market with booming telehealth and telemedicine trends. It radically transformed traditional healthcare operations, driving patient inclination towards online consultation services. DTC genetic tests (DTC-GT) gained momentum allowing patients to understand their genetic profiles without any need for physician intervention.
Moreover, the introduction of strict lockdown restrictions and social distancing norms deployed to curb the spread of the virus prompted patients to adopt digital health alternatives to address their medical and therapeutic needs. The growing popularity of e-pharmacy and online drug stores also complemented the industry outlook.
The direct-to-consumer genetic testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Test Type
- Carrier testing
- Predictive testing
- Ancestry & relationship testing
- Nutrigenomic testing
- Skincare testing
- Others
By Technology
- Targeted analysis
- Single nucleotide polymorphism (SNP) chips
- Whole genome sequencing [WGS]
By Distribution Channel
- Online platforms
- Over-the-counter
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy